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The use of computed tomography (CT) perfusion (CTP) imaging to assess patients with acute ischemic stroke 
can improve patient selection for revascularisation therapy1,2 
and may have particular value in selection beyond current 
time windows. Widespread use of CT perfusion in routine 
clinical practice is hindered by methodological differences 
in scan acquisition, scan processing, and interpretation,3 
as well as inconsistency in perfusion parameters used for 
patient selection. Previous studies assessing interobserver 
reliability of CTP have been limited to mostly single center 
studies with 2 to 4 observers4–11 (Table I in the online-only 
Data Supplement).
In this study, we used an online platform to assess ob-
server agreement on qualitative interpretation of processed 
CT perfusion maps, using observers of different specialty and 
experience.
Background and Purpose—Computed tomography (CT) perfusion (CTP) provides potentially valuable information to 
guide treatment decisions in acute stroke. Assessment of interobserver reliability of CTP has, however, been limited 
to small, mostly single center studies. We performed a large, internet-based study to assess observer reliability of CTP 
interpretation in acute stroke.
Methods—We selected 24 cases from the IST-3 (Third International Stroke Trial), ATTEST (Alteplase Versus Tenecteplase 
for Thrombolysis After Ischaemic Stroke), and POSH (Post Stroke Hyperglycaemia) studies to illustrate various perfusion 
abnormalities. For each case, observers were presented with noncontrast CT, maps of cerebral blood volume, cerebral 
blood flow, mean transit time, delay time, and thresholded penumbra maps (dichotomized into penumbra and core), 
together with a short clinical vignette. Observers used a structured questionnaire to record presence of perfusion deficit, 
its extent compared with ischemic changes on noncontrast CT, and an Alberta Stroke Program Early CT Score for 
noncontrast CT and CTP. All images were viewed, and responses were collected online. We assessed observer agreement 
with Krippendorff-α. Intraobserver agreement was assessed by inviting observers who reviewed all scans for a repeat 
review of 6 scans.
Results—Fifty seven observers contributed to the study, with 27 observers reviewing all 24 scans and 17 observers 
contributing repeat readings. Interobserver agreement was good to excellent for all CTP. Agreement was higher for 
perfusion maps compared with noncontrast CT and was higher for mean transit time, delay time, and penumbra map 
(Krippendorff-α =0.77, 0.79, and 0.81, respectively) compared with cerebral blood volume and cerebral blood flow 
(Krippendorff-α =0.69 and 0.62, respectively). Intraobserver agreement was fair to substantial in the majority of readers 
(Krippendorff-α ranged from 0.29 to 0.80).
Conclusions—There are high levels of interobserver and intraobserver agreement for the interpretation of CTP in acute 
stroke, particularly of mean transit time, delay time, and penumbra maps.   (Stroke. 2019;50:3108-3114. DOI: 10.1161/
STROKEAHA.119.026238.)
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Methods
The data that support the findings of this study are available from the 
corresponding author upon reasonable request
We used the Systematic Image Review System 2 platform, pro-
vided by the University of Edinburgh, an established method similar 
to that used in the ACCESS (Acute Cerebral CT Evaluation of Stroke 
Study) of observer reliability of plain CT in stroke12 and to assess 
>7000 brain scans in the IST-3 (Third International Stroke Trial)13,14 
and other ongoing trials.
We selected 24 cases from 2 clinical trials: IST-3 (imaging sub-
study)15 and the ATTEST trial (Alteplase Versus Tenecteplase for 
Thrombolysis After Ischaemic Stroke)16 and 1 observational study, 
the POSH study (Post Stroke Hyperglycaemia).17 Patients with is-
chemic stroke in all of these studies had CTP performed within 6 
hours of symptom onset. All 3 studies were approved by relevant re-
search ethics committees, and all participants had given consent for 
their anonymized scans to be used in further research.
For standardization, all raw perfusion imaging data were post-
processed by one researcher on a commercially available software 
platform (MiStar, Apollo Medical Imaging Technology, Melbourne, 
Australia) to produce maps of cerebral blood volume (CBV), cere-
bral blood flow (CBF), mean transit time (MTT), delay time (DT), 
and thresholded penumbra maps (PM). PMs dichotomized the lesion 
into core, defined as tissue with CBF of <40% and relative DT of >2 
s compared with homologous tissue in the contralesional hemisphere, 
and penumbra, defined as tissue with relative DT of >2 s but rela-
tive CBF of ≥40% of that in the contralesional hemisphere.18 Scans 
varied in their range of z-axis coverage and in the extent of the vis-
ible perfusion lesions. All scans covered the level of the basal ganglia 
and supraganglionic level required for calculation of Alberta Stroke 
Program Early CT (ASPECT) score.
Clinicians were invited to participate in the study through ad-
vertisement at stroke meetings and emails sent through professional 
organizations’ and trials’ mailing lists. Scan readers’ details were col-
lected at study registration including age, specialization, country and 
hospital where they worked, years of experience in their specialties, 
and frequency of reviewing stroke imaging and perfusion imaging. 
Participants were allowed to review as many scans as they could, in 
any order. Observers were presented with noncontrast CT (NCCT) and 
perfusion maps. A short clinical vignette which included age, National 
Institutes of Health Stroke Scale, and time from onset to scan was pre-
sented to observers after scans were fully reported. Participants could 
alter window settings for the NCCT, but not for the perfusion maps.
A structured questionnaire, adapted from a previously validated 
ischemic stroke questionnaire,12,14,19 asked observers to comment on 
presence of an acute ischemic lesion on NCCT, its size, location, 
swelling, presence of a hyper-attenuated artery, background brain 
changes (old infarct, leukoaraiosis, brain atrophy), and on the pres-
ence of any perfusion deficit, its extent compared with ischemic 
changes on NCCT reflecting a previously used approach for assessing 
mismatch of perfusion lesions relative to the visible CT (or magnetic 
resonance imaging) lesion (no perfusion deficit <20% difference, 
equal volumes, >20% difference compared with the NCCT hypoden-
sity), and the ASPECT score for hypodensity on NCCT and CTP 
maps. ASPECT score is a well-established semiquantitative scoring 
system for assessing the anatomic extent of acute ischemic changes 
in anterior circulation stroke20 (http://www.aspectsinstroke.com) ini-
tially developed for NCCT but adapted for analysis of other imaging 
modalities including CTP.21
At the start of the study, the questionnaire only allowed the ob-
server to calculate an ASPECT score if acute ischemic changes were 
reported in the middle cerebral artery territory, but this restriction 
was later removed. Observers were also allowed to indicate if an 
ASPECT score could not be calculated for perfusion maps when the 
relevant region was not included. The total ASPECT score, ranging 
from 0 to 10 was used for analyses.
To assess intraobserver agreement, observers who completed all 
scans were invited to perform repeat review of 6 scans blind to their 
initial scoring, including 1 with no perfusion deficit, 2 with small to 
moderate perfusion deficit, and 3 with large perfusion deficit.
Statistical analysis was performed using IBM SPPS software, 
version 21. Descriptive statistics were used for scan and observer 
baseline characteristics and χ2 tests to compare categorical data be-
tween groups. Krippendorff α,22 was used to assess inter and intrao-
bserver agreement, using an appropriate macro for SPSS.23 Possible 
Krippendorff-α values range from −1.0 to +1.0, where +1.0 equates 
to perfect agreement, 0.0 means no agreement, and −1.0 implies per-
fect disagreement. Levels of agreement were interpreted as follows: 
0 to 0.2 =slight, 0.21 to 0.4 =fair, 0.41 to 0.6 =moderate, 0.61 to 0.8 
=substantial, 0.81 to 1.00 =almost perfect agreement.24 Analysis was 
performed for all observers and repeated for readers who reported all 
scans and for different reader and scan subgroups.
Results
The clinical and radiological features of the 24 cases used in 
the study are summarized in Table 1.Scans were classified into 
3 groups based on visual assessment of the perfusion deficit 
on PM: no perfusion deficit (4 scans), mild to moderate per-
fusion deficit (11 scans), and large perfusion deficit (9 scans). 
Examples are shown in Figure 1. Perfusion scans varied in 
their z coverage and slice thickness. Most scans (13/24) cov-
ered a 4 cm slab, acquired as 8×5 mm slices.
Fifty-seven observers participated in the study (Table 2), 
of whom 27 (47%) reviewed all scans, and 17 out of 27 (63 %) 
contributed repeat readings to determine intraobserver agree-
ment (Figure 2). Reviewers were from 10 countries, with most 
(36/57, 63%) working in the United Kingdom. There was no 
difference in experience, distribution of specialties, or fre-
quency of viewing stroke scans between the observers who 
completed all scans and those who did not (Table II in the 
online-only Data Supplement). The median number of scans 
reviewed per observer was 19 (interquartile range, 2–24; 
Figure I in the online-only Data Supplement). Observers 
tended to read scans in the order in which they were presented, 
with 56 out of 57(98%) of observers reporting scan 1, and 24 
out of 57(42%) of observers reporting scan 24.
Interobserver agreement was fair to substantial for recog-
nition of acute lesion on NCCT and on the different perfu-
sion maps and fair to moderate for the extent of CTP-NCCT 
mismatch (Table III in the online-only Data Supplement) with 
higher agreement for MTT and DT and PMs. Agreement on 
total ASPECT score was substantial to almost perfect, with 
agreement for MTT, DT, and PM higher than agreement for 
Table1. Clinical and Radiological Features of Cases Used
Clinical features
  Age, y (mean±SD) 73.6 (±11.3)
  Sex (n; male/female) 18/6
  NIHSS on admission, median (IQR) 10 (8–18)
  Affected hemisphere (n; right /left) 9/14
  Time from onset to scan, min, median (IQR) 221(165–268)
Radiological features
  z-axis coverage, mm, median (range) 40 (16–155)
  No. of slices in perfusion imaging, median (range) 8 (2–31)
  Slice thickness, mm, median (range) 5 (4–12)
In 1 scan, there was no clear lateralization. IQR indicates interquartile range; 
and NIHSS, National Institutes of Health Stroke Scale.
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NCCT, CBV, and CBF (Figure 3). Agreement was slightly 
higher for the group that reviewed all scans compared with 
those who reviewed some scans only (Figures II, III, and IV in 
the online-only Data Supplement). Agreement varied among 
different observer and scan subtypes with the highest agree-
ment among neuroradiologists (Tables IV through XV in the 
online-only Data Supplement).
Seventeen observers contributed to the intraobserver 
agreement part of the study (results shown in Figure 4). There 
were no differences in observer characteristics between those 
who did and did not undertake repeat readings (Table II in the 
online-only Data Supplement). The time between finishing the 
first set of readings and starting the repeat reading ranged from 
36 to 314 days (median=233 days.). The shortest duration be-
tween finishing the first reading and starting repeat reading 
was 1 month. Levels of agreement varied widely between ob-
server subgroups from slight to almost perfect (Tables XVI 
through XXVII in the online-only Data Supplement), with 
highest agreement for time-based parameters.
Discussion
The role of CTP in patients with acute stroke presenting within 
treatment windows of 4.5 hours for intravenous thrombolysis 
or 6 hours for endovascular thrombectomy remains uncer-
tain, with some centers advocating routine use,25 whereas 
others do not undertake CTP routinely due to concerns, such 
as delayed door to needle time or physician unfamiliarity.26,27 
Inconsistency in analysis software and proposed analysis 
parameters is likely to contribute to uncertainty and delay. 
Our study showed moderate to near-perfect interobserver and 
intraobserver agreement for time-based CTP parameters (DT 
and MTT) across observers with a wide range of experience 
and backgrounds.
Our results are consistent with previous studies that in-
cluded few observers and fewer scans4–11 and extend these 
previous reports by using a wider spectrum of observers and 
a larger number of scans, including repeat assessment to es-
tablish intraobserver agreement. Differences in the statistical 
measures used mean that direct comparisons with previous 
studies are difficult, but the main findings are in agreement, 
namely, that interobserver agreement is higher for perfusion 
parameters compared with NCCT, for time-based perfusion 
parameters (MTT, DT) and for penumbra/core dichotomized 
maps compared with CBV and CBF. More extensive brain 
coverage improved interobserver agreement. These trends 
were stable across all scan and reader subgroups. We also 
found higher agreement for neuroradiologists versus other 
specialties, although this was not explained by frequency of 
interpreting stroke or perfusion scans or years in speciality. 
Agreement was low in scans with limited z-axis coverage, but 
the size of the perfusion lesion had no effect.
The visual comparison of the perfusion lesion rela-
tive to the NCCT lesion size is analogous to the mismatch 
approach initially described for magnetic resonance imaging, 
with the hypoattenuation of brain on NCCT corresponding 
to ischemic core of largely irreversible damaged tissue28 and 
Figure 1. Examples of scans used in the study. Scans were selected to show variable sizes of perfusion deficit as seen on penumbra map.Dow
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more extensive hypoperfused tissue defined by prolonged 
MTT or DT corresponding to the potentially reversible pe-
numbra. Because the conspicuity of acute ischemic tissue on 
NCCT is poor compared with diffusion-weighted magnetic 
resonance imaging, it is unsurprising that the agreement was 
lower for mismatch than for ASPECTS, which only depends 
on the perfusion component. Reduced CBF or CBV on CTP 
correlate more closely with the diffusion-weighted imaging 
lesion, but the discrimination of normal from reduced CBV 
or CBF is more difficult compared with time-based param-
eters. In general, MTT and DT are more uniform across gray 
and white matter, and between brain regions, than CBF and 
CBV which differ more between gray and white matter, and 
between brain regions, although all perfusion parameters 
are abnormal in old ischemic lesions and regions of leuko-
araiosis.29 CBV additionally has a narrow range of normal 
values. Interobserver and intraobserver agreement for CBF 
and CBV was similar to that for NCCT. Observer agreement 
for ASPECT scores applied to perfusion maps showed bet-
ter agreement for time-based CTP and PMs compared with 
NCCT, CBF, or CBV, with agreement levels unaffected by 
the size of the ischemic lesion. This suggests that the visual 
interpretation of ischemic core on CT-based imaging is more 
consistent when readers use time-based perfusion parameters 
and a standardized scoring tool.
In previous studies, the volume of ischemic core tissue 
was weakly associated with higher risk of adverse outcomes 
in patients treated with reperfusion therapies, including for in-
farct swelling and symptomatic intracerebral haemorrhage30,31; 
in several recent trials, a large core constituted an exclusion 
criterion, although an interaction of core volume and treat-
ment effect could not be demonstrated.15,32
The r esults of this study should be interpreted in view of its 
limitations. The observers were volunteers, presumably having 
some interest in CT perfusion imaging, and agreement may 
be different in the wider population of doctors routinely deal-
ing with stroke imaging. The online platform experience devi-
ates from real-life experience in several important aspects; all 
parameters are available to the observer simultaneously, so that 
interpretation of NCCT can be influenced by findings in CTP, 
as appears to have been the case here, and the time pressure 
related to reviewing a scan to make a treatment decision is not 
a factor. To reduce observer bias in the study through knowing 
stroke severity, the clinical information was introduced after 
the scans were reviewed to test readers’ ability to detect scan 
findings without influence of clinical findings, but this is the 
reverse of clinical practice. The range of abnormalities in the 
scans we selected was limited to patients with mainly middle 
cerebral artery territory strokes. Finally, these results are lim-
ited to visual interpretation of perfusion maps produced by a 
single software and may not represent agreement with other 
software or means of presenting perfusion data.
Summary
Observer agreement on interpretation of CTP perfusion was 
fair to substantial, with better agreement for time-based 
sequences (MTT, DT) and threshold-based core/PMs than 
with CBF, CBV, or NCCT hypoattenuation. Agreement was 
higher when using the ASPECT score, compared with esti-
mating the size of the perfusion lesion relative to the NCCT 
lesion, or to the presence versus absence of the perfusion 
lesion. Intraobserver agreement was also better with time-
based maps, but varied significantly among individuals, show-
ing opportunity for improvement.
Appendix
Study Collaborators
Alessandro Adami, Stroke Centre, Ospedale Sacro Cuore Don 
Calabria, Negrar, Italy. Alfonso Cerase, Unit of Neuroradiology, NHS 
Table 2. Different Observer Characteristics
No. of Observers Percent
Observer specialty
  Neuroradiologist 24 42
  Neurologist 14 25
  Stroke physician 12 21
  Other* 7 12
Hospital type
  University 51 89
  General 6 12
How often do you review stroke imaging?
  Daily 43 75
  Less than daily 14 25
How often do you view perfusion imaging?
  Weekly 20 35
  Monthly 12 21
  Less frequently 25 44
Observer age
  ≥40 y 30 53
  <40 y 27 47
Years of specialization
  ≤5 y 28 49
  6 to 15 y 19 33
  >15 y 10 18
*Other specialties included 3 geriatricians, 1 general radiologist, 1 general 
physician, and 2 not specified.
Figure 2. Number of scan reviews generated.
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& University General Hospital “Santa Maria alle Scotte,” Siena, Italy. 
Ana Garcia, Acute Stroke Unit, Worcestershire Royal Hospital, 
Worcester, United Kingdom. Anders von Heijne, Department of 
Diagnostic Radiology, Danderyd Hospital, Stockholm, Sweden. 
Andre Peeters, UCL St Luc, Brussels, Belgium. Anders von Heijne, 
Department of Radiology, Danderyd Hospital, Stockholm, Sweden. 
Andrea Zini, Stroke Unit, Neurology Clinic, Modena, Italy. Angelo 
Carneiro, Neuroradiology Department, Hospital Geral de Santo 
António, Porto, Portugal. Chris Patterson, Department of Elderly 
Care, Bradford Royal Infirmary, Bradford, United Kingdom. 
Christine Roffe, University Hospital of North Staffordshire, Stoke-
on-Trent, United Kingdom. Daniel Freedman, National Hospital, 
London, United Kingdom. Daniel Scoffings, Department of 
Radiology, Addenbrookes Hospital, Cambridge, United Kingdom. 
Figure 3. Krippendorff α values and 95% CIs for interobserver agreement on interpretation of noncontrast computed tomography (NCCT) and perfusion 
maps (PM). ASPECT indicates Alberta Stroke Program Early CT; CBF, cerebral blood flow; CBV, cerebral blood volume; DT, delay time; and MTT, mean tran-
sient time.
Figure 4. Mean Krippendorff α and 95% CIs of the mean for intraobserver agreement on interpretation of noncontrast computed tomography (NCCT) and 
perfusion maps (PM). Intraobserver agreement for total Alberta Stroke Program Early CT (ASPECT) score for different sequences. CBF indicates cerebral 
blood flow; CBV, cerebral blood volume; CTP, computed tomography perfusion; DT, delay time; and MTT, mean transient time.
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Derk W Krieger, University Hospital of Copenhagen, Copenhagen, 
Denmark. Dipayan Mitra, Department of Neuroradiology, Royal 
Victoria Infirmary, Newcastle upon Tyne, United Kingdom. Eivind 
Berge, Department of Internal Medicine, Oslo University Hospital, 
Oslo, Norway. Elena Adela Cora, University of Newcastle Upon Tyne, 
Newcastle, United Kingdom. Eoin O’Brien, Addenbrookes Hospital, 
Cambridge, United Kingdom. Eric Bertholds, Kärnsjukhuset 
Skövde, Sweden. Ethem Murat, Department of Neurology, 
Arsava Hacettepe University, Ankara, Turkey. Fiona Moreton, 
Southern General Hospital, Glasgow United Kingdom. Garryck 
Tan, Radiology Department, Darent Valley Hospital, Dartford, 
United Kingdom. Gillian Potter, Department of Neuroradiology, 
Salford, United Kingdom. Giuseppe Rinaldi, Azienda Ospedaliero-
Universitaria “Ospedali Riuniti” di Foggia, Foggia, Italy. Jeremy 
Madigan, Department of Neuroradiology, Atkinson Morley’s 
Hospital, London, United Kingdom. Joe Leyon, Queen Elizabeth 
Hospital, Birmingham, United Kingdom. Johann Du Plessis, Institute 
for Neurological Sciences, Southern General Hospital Glasgow, 
United Kingdom. Jonathan Hewitt, University Hospital Llandough, 
Cardiff, United Kingdom. José Eduardo Alves, Hospital Geral de 
Santo António, Porto, Portugal. Jose Egido, Hospital Clinico San 
Carlos, Madrid, Spain. Laszlo Sztriha, Department of Neurology, 
King’s College Hospital, London, United Kingdom. Magnus 
Esbjoernsson, Narsjukvardskliniken. Hassleholm, Sweden. Manuel 
Correia, Serviço de Neurologia,Hospital Geral de Santo António, 
Porto, Portugal. Martin Griebe, Universitätsklinikum, Mannheim, 
Mannheim, Germany. Michelle Dharmasiri, Poole Hospital, Poole, 
United Kingdom. Olga Kirmi, St Mary’s NHS Trust, London, United 
Kingdom. Olivia Geraghty, St Mary’s NHS Trust, London, United 
Kingdom. Pablo García-Bermejo, Hospital Clínico Universitario, 
Valladolid, Spain. Patrick Sutton, Norfolk and Norwich University 
Hospital, Norwich, United Kingdom. Pervinder Bhogal, Karolinska 
Hospital, Stockholm, Sweden. Philip White, Institute of Neuroscience, 
University of Newcastle Upon Tyne, Newcastle, United Kingdom. 
Phillip Ferdinand, University Hospital of North Staffordshire, Stoke-
on-Trent, United Kingdom. Qazi Anjum, Department of Stroke 
Medicine, Swansea NHS Trust, Swansea, United Kingdom. Robin 
Sellar, Royal Infirmary Of Edinburgh, Edinburgh, United Kingdom. 
Rüdiger von Kummer, Neuroradiologisches Klinik, Universität, 
Dresden, Germany. Sreeman Andole, Essex Centre for Neurological 
Sciences, Romford, United Kingdom. Sriram Vundavalli, Brighton 
& Sussex University Hospitals, Brighton, United Kingdom. Thomas 
Webb, William Harvey Hospital, Ashford, United Kingdom. Tilak 
Das, Addenbrookes Hospital, Cambridge, United Kingdom. Tomasz 
Matys, Department of Radiology, Addenbrookes Hospital, Cambridge, 
United Kingdom. Tony Goddard, Leeds General Infirmary, Leeds, 
United Kingdom. Vamsi Gontu, Karolinska Hospital, Stockholm, 
Sweden. Vijay Sawlani, Department of Radiology, Queen Elizabeth 
Hospital, Birmingham, United Kingdom. Volker Puetz, Universität 
Dresden, Dresden, Germany. Will Whiteley, Royal Infirmary Of 
Edinburgh, Edinburgh, United Kingdom.
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for Thrombolysis After Ischaemic Stroke) and the POSH (Post Stroke 
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2010/04 and TSA 2006/03). IST-3: Drug and placebo for the 300 
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